Photobiomodulation Before or After Tooth Whitening
1 other identifier
interventional
64
1 country
1
Brief Summary
The objective is to evaluate the effect of photobiomodulation (PBM) applied before or after in-office tooth whitening in reducing tooth sensitivity (TS) and color change. Sixty-six patients aged between 18 and 28 years old, of both sexes, with good oral and general health will be selected for the study. A randomization process will be carried out to allocate participants into the three different groups: FBM-Before, FBM-After and Placebo. All groups will undergo in-office whitening treatment with 35% hydrogen peroxide (Whitness HP, FGM, Joinville, SC, Brazil). Three whitening sessions will be carried out, considering a seven-day interval between sessions. TS will be measured using a visual analogue scale (VAS) and a five-point numerical rating scale (NRS), while shade change will be assessed using a spectrophotometer: before the bleaching treatment (T0), after the first (T1), second (T2). ) and third (T3) weeks of treatment and 30 days (T4) after the end of the bleaching treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 15, 2024
CompletedFirst Submitted
Initial submission to the registry
July 18, 2024
CompletedFirst Posted
Study publicly available on registry
July 24, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 21, 2024
CompletedOctober 23, 2024
October 1, 2024
2 months
July 18, 2024
October 21, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Tooth sensitivity
To assess pain sensitivity, patients will be instructed to fill out a form to record tooth sensitivity, based on individual pain perception. This form will be delivered at each whitening session, and will be returned to the researcher at the next appointment, that is, always one week after each whitening session.
21 days
Secondary Outcomes (1)
Color change
51 days
Study Arms (3)
Placebo
PLACEBO COMPARATOROnly in-office tooth whitening will be performed. Patients will not undergo additional treatments, however, a simulation of the application of FBM will be performed before and after each CD session. The low-power laser (Therapy EC, DMC, São Carlos, SP, Brazil) will be positioned perpendicularly, in contact, over the cervical and apical region of each tooth included in the whitening treatment. During the simulation, the equipment will not be activated, that is, irradiation will not be carried out.
FBM-Before
EXPERIMENTALLow power laser will be used immediately before CD. The energy supplied to each tooth will be 4J, using infrared light (IF) at 808 nm (± 10 nm) at two perpendicular points (located in the apical and cervical region) on the buccal surface of the incisors, canines and premolars. The laser will be operated in continuous mode and an energy of 2J will be applied to each point. The protocol that will be used to treat tooth sensitivity was recommended by the equipment manufacturer. Immediately after each whitening treatment session, a FBM simulation will be performed, in the same way as described for the Placebo group.
FBM-After
EXPERIMENTALThe low-power laser will be used immediately after tooth whitening. The FBM protocol will occur in the same way as described for the FBM-Before group. The FBM simulation will occur before the CD session begins and will occur in the same way as described for the Placebo group.
Interventions
All groups will undergo in-office whitening treatment with 35% hydrogen peroxide (Whitness HP, FGM, Joinville, SC, Brazil). Three whitening sessions will be carried out, considering a seven-day interval between sessions.
Eligibility Criteria
You may qualify if:
- Volunteers of both sexes, in good oral and general health.
- The upper right canine should be classified as color A2 or darker, according to the Vita Classical scale (VITA Zahnfabrik, Bad Sackingen, Germany).
You may not qualify if:
- Active caries or periodontal disease
- Visible cracks in upper or lower anterior teeth
- Evident malocclusion, restorations and prosthetics in anterior teeth
- Gastroesophageal disorders
- Severe internal discoloration of the tooth (tetracycline, fluorosis or pulped teeth)
- Exposure dentin in anterior and/or posterior teeth
- Parafunctional habits
- Tooth sensitivity, previous bleaching treatment or orthodontic treatment
- Pregnant or breastfeeding women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Elma Vieira Takeuchi
Belém, Pará, 66093541, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dra
Study Record Dates
First Submitted
July 18, 2024
First Posted
July 24, 2024
Study Start
July 15, 2024
Primary Completion
September 15, 2024
Study Completion
October 21, 2024
Last Updated
October 23, 2024
Record last verified: 2024-10